This study aimed to validate the scoring criteria for digital cervicography. The study enrolled 300 women submitted to a clinical protocol using cytological examination alone, digital cervicography without image magnification (Evaluation 1), and digital cervicography plus additional image magnification and considering the positive criteria (Evaluation 2). Women's mean age was 27.6 years. Positive criteria for digital cervicography were identified in 111 positive cases with pre-cancerous cervical lesions (100%) and in 8 cases classified as false positives (2.6%). Evaluations 1 and 2 classified the tests as positive (163; 54.3%) and suspected (146; 48.6%), respectively. According to the findings, digital cervicography was more sensitive (99.1%) and cytology more specific (100%). Digital cervicography sensitivity increased by 4.5 times when the positive criteria were applied as compared to cytology alone, besides involving low cost, thus suggesting that it is a viable technique.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1590/s0102-311x2008001100020 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Introduction: Visual Inspection with Acetic Acid (VIA) has been adopted for cervical cancer screening in Kenya and other Low-Middle Income Countries despite providing suboptimal results among HIV-infected women. It is mostly performed by nurses in health centers. Innovative ways of improving the performance of VIA in HIV-infected women are desired.
View Article and Find Full Text PDFHuman Papillomavirus Types and Cervical Cancer Screening among Female Sex Workers in Cameroon.
Cancers (Basel)
January 2024
Center for Women's Reproductive Health, Department of Obstetrics & Gynecology, University of Alabama at Birmingham, 1700 6th Avenue South, Suite 10270, Birmingham, AL 35233, USA.
Article Synopsis
- * Out of 599 FSWs screened, 62.1% tested positive for HPV, with type 51 being the most common, and HIV-positive FSWs were found to be 1.65 times more likely to have HPV than HIV-negative individuals.
- * Only 9.9% of FSWs were positive for visual inspections indicating possible precancerous lesions, highlighting a significant health concern for this population.
Artificial intelligence for cervical cancer screening: Scoping review, 2009-2022.
Int J Gynaecol Obstet
May 2024
OMICAS Research Institute (iOMICAS), Pontificia Universidad Javeriana Cali, Cali, Colombia.
Article Synopsis
- - The integration of artificial intelligence (AI) in cancer research is growing, particularly in analyzing diagnostic images for cervical cancer, with a review of literature conducted under systematic guidelines.
- - A comprehensive search identified 32 studies from 2009 to 2022, highlighting various AI algorithms like support vector machines, deep learning methods, and their performance in diagnosing cervical cancer from sources such as digital colposcopy and cervicography.
- - Results indicated that deep learning techniques, especially convolutional neural networks, achieved over 97% accuracy in diagnosis, suggesting promising advancements, yet emphasizing the need for more research to confirm these outcomes.
Implementing Smartphone-Based Telemedicine for Cervical Cancer Screening in Uganda: Qualitative Study of Stakeholders' Perceptions.
J Med Internet Res
October 2023
Uganda Cancer Institute, Kampala, Uganda.
Background: In Uganda, cervical cancer (CaCx) is the commonest cancer, accounting for 35.7% of all cancer cases in women. The rates of human papillomavirus vaccination and CaCx screening remain low.
View Article and Find Full Text PDFDigital cervicography for cervical cancer screening in low-resource settings: A scoping review.
Gynecol Oncol Rep
February 2023
University of Oklahoma College of Medicine, 900 NE 10 St, Oklahoma City, OK 73104, United States.
Introduction: Digital cervicography (DC) is a method of capturing images for analysis during visual inspection with acetic acid (VIA) for cervical cancer screening. Cervical cancer is the 3rd leading cause of female cancer in the world with approximately 90 % of deaths due to cervical cancer occurring in low and middle income countries (LMICs). The need for cost-effective and sustainable methods for screening is vital in these settings.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!